338
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Polyester-based microparticles of different hydrophobicity: the patterns of lipophilic drug entrapment and release

, , &
Pages 199-208 | Received 27 Jul 2015, Accepted 18 Jan 2016, Published online: 18 Feb 2016

References

  • Albertsson AC, Srivastava RK. Recent developments in enzyme-catalyzed ring-opening polymerization. Adv Drug Deliv Rev Rev, 2008;60(9):1077–93.
  • Biggs DL, Lengsfeld CS, Hybertson BM, Ng KY, Manning MC, Randolph TW. In vitro and in vivo evaluation of the effects of PLA microparticle crystallinity on cellular response. J Control Release, 2003;92(1–2):147–61.
  • Choi JS, Seo K, Yoo JW. Recent advances in PLGA particulate systems for drug delivery. J Pharma Investig, 2012;42(3):155–63.
  • Chung TW, Huang YY, Tsai YL, Liu YZ. Effects of solvent evaporation rate on the properties of protein-loaded PLLA and PDLLA microspheres fabricated by emulsion-solvent evaporation process. J Microencapsulation, 2002;19(4):463–71.
  • Cohen LJ. Risperidone. Pharmacotherapy, 1994;14(3):253–65.
  • Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 2001;13(2):123–33.
  • Dalmoro A, Barba AA, Lamberti M, Mazzeo M, Venditto V, Lamberti G. Random l-lactide/ɛ-caprolactone copolymers as drug delivery materials. J Materials Sci, 2014;49(17):5986–96.
  • Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release, 2012;161(2):505–22.
  • du Noüy PL. Spontaneous decrease of the surface tension of serum. I. J Exp Med, 1922;35(4):575–97.
  • Dunne M, Corrigan OI, Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials, 2000;21(16):1659–68.
  • Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev Rev, 2012;64(6):557–70.
  • Frank A, Rath SK, Venkatraman SS. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J Control Release, 2005;102(2):333–44.
  • Frelichowska J, Bolzinger MA, Pelletier J, Valour JP, Chevalier Y. Topical delivery of lipophilic drugs from o/w Pickering emulsions. Int J Pharm, 2009;371(1–2):56–63.
  • Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsulation, 2005;22(7):705–14.
  • Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urologic Oncology, 2008;26(1):57–64.
  • Izumikawa S, Yoshioka S, Aso Y, Takeda Y. Preparation of poly(L-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. J Controlled Release, 1991;15:133–40.
  • Karavelidis V, Karavelidis V, Giliopoulos D, Karavas E, Bikiaris D. Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior. European J Pharmaceutical Sci, 2010;41(5):636–43.
  • Kim M, Pack DW. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood, 1998;91(11):4106–17.
  • Korzhikov V, Gusevskaya KV, Litvinchuk EN, Vlakh EG, Tennikova TB. Enzyme-mediated ring-opening polymerization of pentadecalactone to obtain biodegradable polymer for fabrication of scaffolds for bone tissue engineering. Int J Polymer Sci, 2013;2013:476748.
  • Kowalski A, Duda A, Penczek S. Mechanism of cyclic ester polymerization initiated with tin(II) octoate. 2. macromolecules fitted with tin(II) alkoxide species observed directly in MALDI − TOF spectra. Macromolecules, 2000;33(3):689–95.
  • Kuentz M. Lipid-based formulations for oral delivery of lipophilic drugs. Drug Discov Today Technol, 2012;9(2):e97–104.
  • Kumar A, et al. Efficient ring-opening polymerization and copolymerization of -Caprolactone and ω-pentadecalactone catalyzed by Candida antartica lipase B. Macromolcules, 2000;33:6303–9.
  • Lai MK, Tsiang RCC. Microencapsulation of acetaminophen into poly(L-lactide) by three different emulsion solvent-evaporation methods. J Microencapsulation, 2005;22(3):261–74.
  • Li J, Sabliov C. PLA/PLGA nanoparticles for delivery of drugs across the blood-brain barrier. Nanotechnology Rev, 2013;2(3):241–57.
  • Miyajima M, Koshika A, Okada J, Ikeda M, Nishimura K. Effect of polymer crystallinity on papaverine release from poly(L-lactic acid) matrix. J Controlled Release, 1997;49(2–3):207–15.
  • Odeberg JM, Kaufmann P, Kroon KG, Höglund P. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur J Pharm Sci, 2003;20(4–5):375–82.
  • Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRx J. Am Soc Exp NeuroTher, 2005;2(1):108–19.
  • Pan J, Feng SS. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials, 2008;29(17):2663–72.
  • Pawar AA, Chen DR, Venkataraman C. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices. Int J Pharm, 2012;430(1–2):228–37.
  • Péan JM, Venier-Julienne MC, Filmon R, Sergent M, Phan-Tan-Luu R, Benoit JP. Optimization of HSA and NGF encapsulation yields in PLGA microparticles. Int J Pharm, 1998;166(1):105–15.
  • Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov, 2007;6(3):231–48.
  • Rawat A, Bhardwaj U, Burgess DJ. Comparison of in vitro-in vivo release of Risperdal(®) Consta(®) microspheres. Int J Pharm, 2012;434(1–2):115–21.
  • Stridsberg K, Ryner M, Albertsson A. Controlled ring-opening polymerization: Polymers with designed macromolecular architecture. Adv Polymer Sci, 2002;157:1–25.
  • Su ZX, Shi Y-N, Teng L-S, Li X, Wang L, Meng Q-F, Teng L-R, Li Y-X. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Pharm Develop Technol, 2011;16(4):377–84.
  • Tamboli V, Mishra GP, Mitra AK. Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA)-based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles. Colloid Polymer Sci, 2013;291(5):1235–45.
  • Tong R, Coyle VJ, Tang L, Barger AM, Fan TM, Cheng J. Polylactide nanoparticles containing stably incorporated cyanine dyes for in vitro and in vivo imaging applications. Microsc Res Tech, 2010;73(9):901–9.
  • Xiong XY, Tam KC, Gan LH. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles. J Control Release, 2005;103(1):73–82.
  • Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release, 1999;60(2–3):179–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.